Artificial intelligence technology in Alzheimer's disease research

IF 1.1 Q2 MEDICINE, GENERAL & INTERNAL Intractable & rare diseases research Pub Date : 2023-01-01 DOI:10.5582/irdr.2023.01091
Wenli Zhang, Yifan Li, Wentao Ren, Bo Liu
{"title":"Artificial intelligence technology in Alzheimer's disease research","authors":"Wenli Zhang, Yifan Li, Wentao Ren, Bo Liu","doi":"10.5582/irdr.2023.01091","DOIUrl":null,"url":null,"abstract":"Alzheimer's disease is a neurocognitive disorder and one of the contributing factors to dementia. According to the World Health Organization, this disease has a sig-nificant impact on the global population's health, with the number of affected individuals steadily increasing each year. Amidst rapid technological development, the use of artificial intelligence has significantly expanded into the field of medical diagnostics, encompassing areas such as the analysis of medical images, drug development, design of personalized treatment plans, and disease prediction and treatment. Deep learning, which is an important branch in the field of artificial intelligence, is playing a key role in solving several medical challenges by providing important technical support for the early detection, diagnosis, and treatment of Alzheimer's disease. Given this context, this review aims to explore the differences between conventional methods and artificial intelligence techniques in Alzheimer's disease research. Additionally, it aims to summarize current non-invasive and portable techniques for detection of Alzheimer's disease, offering support and guidance for the future prediction and management of the disease.","PeriodicalId":14420,"journal":{"name":"Intractable & rare diseases research","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intractable & rare diseases research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5582/irdr.2023.01091","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Alzheimer's disease is a neurocognitive disorder and one of the contributing factors to dementia. According to the World Health Organization, this disease has a sig-nificant impact on the global population's health, with the number of affected individuals steadily increasing each year. Amidst rapid technological development, the use of artificial intelligence has significantly expanded into the field of medical diagnostics, encompassing areas such as the analysis of medical images, drug development, design of personalized treatment plans, and disease prediction and treatment. Deep learning, which is an important branch in the field of artificial intelligence, is playing a key role in solving several medical challenges by providing important technical support for the early detection, diagnosis, and treatment of Alzheimer's disease. Given this context, this review aims to explore the differences between conventional methods and artificial intelligence techniques in Alzheimer's disease research. Additionally, it aims to summarize current non-invasive and portable techniques for detection of Alzheimer's disease, offering support and guidance for the future prediction and management of the disease.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人工智能技术在阿尔茨海默病研究中的应用
阿尔茨海默病是一种神经认知障碍,是导致痴呆症的因素之一。据世界卫生组织称,这种疾病对全球人口的健康有重大影响,受影响的人数每年都在稳步增加。随着技术的快速发展,人工智能的应用已经显著扩展到医学诊断领域,包括医学图像分析、药物开发、个性化治疗方案设计、疾病预测和治疗等领域。深度学习是人工智能领域的一个重要分支,通过为阿尔茨海默病的早期发现、诊断和治疗提供重要的技术支持,在解决多项医学挑战方面发挥着关键作用。在此背景下,本文旨在探讨传统方法与人工智能技术在阿尔茨海默病研究中的差异。同时,总结目前无创、便携的阿尔茨海默病检测技术,为阿尔茨海默病的未来预测和管理提供支持和指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Intractable & rare diseases research
Intractable & rare diseases research MEDICINE, GENERAL & INTERNAL-
CiteScore
2.10
自引率
0.00%
发文量
29
期刊最新文献
A patient treated with ofatumumab for myasthenia gravis in conjunction with systemic lupus erythematosus and thyroid carcinoma. Cost-utility analysis of romiplostim for the treatment of chronic primary immune thrombocytopenia in China. Epidemiological estimates of paroxysmal nocturnal hemoglobinuria in Bulgaria. Functional impairments in NBIA patients: Preliminary results. Genetic analysis of a novel FBN1 mutation in a pediatric Marfan syndrome patient.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1